Anebulo Pharmaceuticals (ANEB) Institutional Ownership $1.27 +0.11 (+9.48%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Anebulo Pharmaceuticals (NASDAQ:ANEB)CurrentInstitutional OwnershipPercentage28.40%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$21.37MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$382.09K Get ANEB Insider Trade Alerts Want to know when executives and insiders are buying or selling Anebulo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANEB Institutional Buying and Selling by Quarter Anebulo Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.47,954$62K0.0%N/A0.117% 4/9/2025 LVW Advisors LLC349,617$455K0.1%-44.7%0.851% 2/17/2025 22NW LP15,467,300$25.99M18.5%+188.2%59.650% 2/14/2025 Nantahala Capital Management LLC3,036,325$5.10M0.2%+494.1%11.710% 2/7/2025 King Luther Capital Management Corp59,662$100K0.0%N/A0.230% 1/16/2025 LVW Advisors LLC632,516$1.06M0.1%-1.3%2.439% 1/16/2024 LVW Advisors LLC643,039$1.56M0.3%-4.4%2.509% 2/8/2023Herr Investment Group LLC29,644$72K0.0%N/A0.116% 11/10/2022 Nantahala Capital Management LLC511,073$1.43M0.1%N/A1.994% 10/14/2022 LVW Advisors LLC674,964$1.89M0.4%-3.6%2.888% 7/22/2022 LVW Advisors LLC700,000$3.64M0.7%N/A2.999% 8/18/2021 Ikarian Capital LLC174,811$1.20M0.1%N/A0.749% 8/17/2021 22NW LP3,343,565$22.80M6.1%N/A14.322% 8/17/2021 Boothbay Fund Management LLC19,835$135K0.0%N/A0.085% 8/13/2021 Laurion Capital Management LP225,000$1.55M0.0%N/A0.964% (Data available from 1/1/2016 forward) ANEB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANEB shares? During the previous two years, the following institutional investors and hedge funds held shares of Anebulo Pharmaceuticals shares: 22NW LP ($25.99M), Nantahala Capital Management LLC ($5.10M), LVW Advisors LLC ($455K), and King Luther Capital Management Corp ($100K), Goldman Sachs Group Inc. ($62K).Learn more on ANEB's institutional investors. What percentage of Anebulo Pharmaceuticals stock is owned by institutional investors? 28.40% of Anebulo Pharmaceuticals stock is owned by institutional investors. Learn more on ANEB's institutional investor holdings. Which institutional investors have been buying Anebulo Pharmaceuticals stock? The following institutional investors have purchased Anebulo Pharmaceuticals stock in the last 24 months: 22NW LP ($10.10M), Nantahala Capital Management LLC ($2.53M), King Luther Capital Management Corp ($59.66K), and Goldman Sachs Group Inc. ($47.95K). How much institutional buying is happening at Anebulo Pharmaceuticals? Institutional investors have bought a total of 12,733,878 shares in the last 24 months. This purchase volume represents approximately $21.37M in transactions. Which Anebulo Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Anebulo Pharmaceuticals stock in the last 24 months: LVW Advisors LLC ($320.71K). How much institutional selling is happening at Anebulo Pharmaceuticals? Institutional investors have sold a total of 320,714 shares in the last 24 months. This volume of shares sold represents approximately $452.97K in transactions. Related Companies Neumora Therapeutics Major Shareholders INmune Bio Major Shareholders Ventyx Biosciences Major Shareholders DiaMedica Therapeutics Major Shareholders Fate Therapeutics Major Shareholders Actuate Therapeutics Major Shareholders enGene Major Shareholders Larimar Therapeutics Major Shareholders Journey Medical Major Shareholders Tiziana Life Sciences Major Shareholders This page (NASDAQ:ANEB) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
